SPNE stock forecast
Our latest prediction for SeaSpine Holdings Corp's stock price was made on the Dec. 13, 2019 when the stock price was at 11.03$.
In the short term (2weeks), SPNE's stock price should underperform the market by -5.05%. During that period the price should oscillate between -10.06% and +8.18%.
In the medium term (3months), SPNE's stock price should underperform the market by -11.37%. During that period the price should oscillate between -30.30% and +18.68%.
Get email alertsCreate a solid portfolio with SPNE
About SeaSpine Holdings Corp
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.
At the moment the company generates 160M USD in revenues.
On its last earning announcement, the company reported a loss of -1.57$ per share.
The book value per share is 6.89$
Three months stock forecastDec. 13, 2019
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
160M | 63.50% | -43M | -27.00% | -43M | -1.57 | - | - | 28M | 6.89 | -25M | -18M | -43M |